You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients

Citation Tools

Article menu

Download PDFPDF

Oral Plenary
Plenary V
IGCS20_1306
15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rocconi R, Grosen E, Ghamande S, et al
15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients
International Journal of Gynecologic Cancer 2020;30:A11-A12.